Treatment for Glaucoma

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Sinai Hospital, Detroit, Franklin Eye Consultants, Southfield, MI
Glaucoma
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

This study is evaluating whether a sequence of two surgeries can improve vision in people with glaucoma.

See full description

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

0 Treatment Group

This trial involves 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly up to 5 years for reporting.

Closest Location

Sinai Hospital, Detroit, Franklin Eye Consultants - Southfield, MI

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There is one eligibility criterion to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Men and women between the ages of 35 and 80 with open-angle glaucoma that was not successfully controlled by medication were eligible for enrollment

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Glaucoma by sharing your contact details with the study coordinator.